167 related articles for article (PubMed ID: 29150975)
1. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
[TBL] [Abstract][Full Text] [Related]
2. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
3. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
[TBL] [Abstract][Full Text] [Related]
4. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib.
Cheng G; Li Y; Liu Z; Song X
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832
[TBL] [Abstract][Full Text] [Related]
6. Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.
Hijiya N; Tsukamoto Y; Nakada C; Tung Nguyen L; Kai T; Matsuura K; Shibata K; Inomata M; Uchida T; Tokunaga A; Amada K; Shirao K; Yamada Y; Mori H; Takeuchi I; Seto M; Aoki M; Takekawa M; Moriyama M
Cancer Res; 2016 May; 76(9):2612-25. PubMed ID: 26941286
[TBL] [Abstract][Full Text] [Related]
7. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
[TBL] [Abstract][Full Text] [Related]
8. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
[TBL] [Abstract][Full Text] [Related]
9. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells.
Imajo M; Kondoh K; Yamamoto T; Nakayama K; Nakajima-Koyama M; Nishida E
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28483913
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
12. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Mandal J; Yu ZC; Shih IM; Wang TL
J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
[TBL] [Abstract][Full Text] [Related]
13. miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.
Hu N; Tian Y; Song Y; Zang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760201
[TBL] [Abstract][Full Text] [Related]
14. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
De Vriendt V; De Roock W; Di Narzo AF; Tian S; Biesmans B; Jacobs B; Budinska E; Sagaert X; Rossi S; D'Ario G; Delorenzi M; Simon I; Vecchione L; Tejpar S
Biomarkers; 2013 Sep; 18(6):516-24. PubMed ID: 23875912
[TBL] [Abstract][Full Text] [Related]
15. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival.
Kao DD; Oldebeken SR; Rai A; Lubos E; Leopold JA; Loscalzo J; Handy DE
Mol Cell Biochem; 2013 Oct; 382(1-2):153-62. PubMed ID: 23812841
[TBL] [Abstract][Full Text] [Related]
17. DUSP4 inhibits autophagic cell death and apoptosis in colorectal cancer by regulating BCL2-Beclin1/Bax signaling.
Xu W; Nie C; Chen X
Mol Biol Rep; 2023 Apr; 50(4):3229-3239. PubMed ID: 36705792
[TBL] [Abstract][Full Text] [Related]
18. Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis.
Klemm S; Evert K; Utpatel K; Muggli A; Simile MM; Chen X; Evert M; Calvisi DF; Scheiter A
BMC Cancer; 2023 Nov; 23(1):1086. PubMed ID: 37946160
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.
Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Okugawa Y; Shimura T; Hiro J; Uchida K; Mohri Y; Kusunoki M
Med Oncol; 2013; 30(3):620. PubMed ID: 23749251
[TBL] [Abstract][Full Text] [Related]
20. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
